Forte Biosciences, Inc. — Director's Dealing 2021

Sep 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Forte Biosciences, Inc. (FBRX)
CIK: 0001419041
Period of Report: 2021-09-07

Reporting Person: Wagner Paul A. (Director, See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-07	Common Stock	S	1000000	$4.3471	Disposed	1279049	Direct

Footnotes

F1: Represents the weighted average share price of an aggregate total of 1,000,000 shares sold in the price range of $4.1403 to $4.64 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.